PhenomeX Launches the Opto® T Cell Profiling Workflow

This workflow revolutionizes immunotherapy research and development by comprehensively profiling single T cells to correlate polyfunctionality with cytotoxicity and recovery of those same cells for downstream analysis EMERYVILLE, Calif., April 17, 2023 /PRNewswire/ — PhenomeX Inc….

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.